Literature DB >> 10601830

Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances.

A Martínez-Arán1, E Vieta, F Colom, M Reinares, A Benabarre, C Gastó, M Salamero.   

Abstract

Although cognitive dysfunctions in psychosis have classically been associated with schizophrenia, there is clinical evidence that some bipolar patients show cognitive disturbances either during acute phases or in remission periods. The authors critically review the data on cognitive impairment in bipolar disorder. The main computerized databases (Medline, Psychological Abstracts, Current Contents) have been consulted crossing the terms 'cognitive deficits', 'neuropsychology', 'intellectual impairment', 'mania', 'depression' and 'bipolar disorder'. Changes in the fluency of thought and speech, learning and memory impairment, and disturbances in associational patterns and attentional processes are as fundamental to depression and mania as are changes in mood and behavior. Moreover, a significant number of bipolar patients show persistent cognitive deficits during remission from affective symptoms. However, there are several methodological pitfalls in most studies such as unclear remission criteria, diagnostic heterogeneity, small sample sizes, absence of longitudinal assessment, practice effect and poor control of the influence of pharmacological treatment. Most studies point at the presence of diffuse cognitive dysfunction during the acute phases of bipolar illness. Most of these deficits seem to remit during periods of euthymia, but some of them may persist in approximately one third of bipolar patients. Methodological limitations warrant further research in order to clear up the relationship between neuropsychological functioning and clinical, demographic and treatment variables in bipolar disorder. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 10601830     DOI: 10.1159/000012361

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  33 in total

1.  Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status.

Authors:  Kate B Carey; Michael P Carey; Jeffrey S Simons
Journal:  J Nerv Ment Dis       Date:  2003-05       Impact factor: 2.254

Review 2.  The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.

Authors:  Roger S McIntyre; Holly X Xiao; Kahlood Syeda; Maj Vinberg; Andre F Carvalho; Rodrigo B Mansur; Nadia Maruschak; Danielle S Cha
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

3.  Emotional bias in unaffected siblings of patients with bipolar I disorder.

Authors:  Jesse G Brand; Terry E Goldberg; Nisali Gunawardane; Chaya B Gopin; Robyn L Powers; Anil K Malhotra; Katherine E Burdick
Journal:  J Affect Disord       Date:  2011-12-29       Impact factor: 4.839

4.  Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.

Authors:  Katherine E Burdick; Raphael J Braga; Charles U Nnadi; Yaniv Shaya; Walter H Stearns; Anil K Malhotra
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

5.  Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Gitte M Knudsen; Julian Macoveanu; Allan R Hansen; Olaf B Paulson; Hartwig R Siebner; Lars V Kessing
Journal:  Trials       Date:  2010-10-13       Impact factor: 2.279

6.  Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Joel Jakobsson; Henrik Zetterberg; Kaj Blennow; Carl Johan Ekman; Anette G M Johansson; Mikael Landén
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

Review 7.  Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.

Authors:  Katherine E Burdick; Raphael J Braga; Joseph F Goldberg; Anil K Malhotra
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Neurocognitive functioning in the early stages of bipolar disorder: visual backward masking performance in high risk subjects.

Authors:  Anne Duffy; Tomas Hajek; Martin Alda; Paul Grof; Robert Milin; Glenda MacQueen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-23       Impact factor: 5.270

Review 9.  Epidemiology and management of anxiety in patients with bipolar disorder.

Authors:  Marcia Kauer-Sant'Anna; Flavio Kapczinski; Eduard Vieta
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

10.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.